Значения термина mimetic compounds на английском

MF275 apparently activates a virus entry pathway parallel to that triggered by CD4 and CD4- mimetic compounds.

We found that small-molecule CD4- mimetic compounds sensitize HIV-1 to antibodies that can be elicited in vaccinated humans and monkeys.

Understanding the mechanistic factors that influence the activity of CD4- mimetic compounds can help to improve their potency and coverage of diverse HIV-1 strains.

Thus, in addition to their direct antiviral effect, CD4- mimetic compounds dramatically enhance the HIV-1-neutralizing activity of antibodies that can be elicited with currently available immunogens.